CELHNASDAQConsumer Defensive

CELSIUS HOLDINGS INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$32.16

+7.06%

Alpha Vantage · 11/6/2026

Industry: Beverages - Non-AlcoholicCategory: Domestic Common StockCurrency: USDNews: 1 recent

Analyze CELH free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

+17.4%

3 months

+18.2%

6 months

-0.4%

1 year

-28.6%

Year to date

-29.7%

52-week range

$23.77 – $56.69

Fundamental snapshot

Latest reported period: Sep 30, 2026

Sharadar reported data

Market cap

$8.06B

P/E

P/B

6.3

P/S

2.5

Revenue

$3.17B

Net income

$317.09M

Diluted EPS

0.89

Gross margin

47.60%

Net margin

7.30%

Return on equity

18.80%

Total debt

$667.76M

Cash

$700.62M

Free cash flow

$269.01M

Latest eight reported quarters

Reported quarterly values, newest first

Period	Revenue	Net income	Gross margin	Net margin	Free cash flow
Sep 30, 2026	$847.23M	$126.96M	46.80%	11.70%	$127.69M
Jun 30, 2026	$817.93M	$55.29M	48.10%	4.50%	$205.48M
Mar 31, 2026	$782.62M	$110.1M	48.30%	10.90%	$65.81M
Dec 31, 2025	$721.63M	$24.74M	47.40%	1.30%	-$129.97M
Sep 30, 2025	$725.11M	-$61.01M	51.30%	-9.70%	$321.46M
Jun 30, 2025	$739.26M	$99.86M	51.50%	11.60%	$35.46M
Mar 31, 2025	$329.28M	$44.42M	52.30%	10.50%	$96.42M
Dec 31, 2024	$332.2M	-$18.88M	50.20%	-7.10%	$70.27M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent CELH news

All market news

lincolnjournal.com·Oct 26, 202657 signal

CELH Deadline: Rosen Law Firm Urges Celsius Holdings, Inc. (NASDAQ: CELH) Stockholders to Contact the Firm for Information About Their Rights

The Rosen Law Firm is reminding investors of a class action lawsuit against Celsius Holdings, Inc. (NASDAQ: CELH) for alleged misrepresentations regarding its business operations. The lawsuit claims Celsius failed to adequately disclose cardiac risks of its Alani Nu products and marketed them to individuals under 18, leading to a "non-speculative risk" of adverse health events. Investors who purchased Celsius securities between February 21, 2025, and June 3, 2026, and wish to serve as lead plaintiff must file their motion by November 3, 2026.

Original source